Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT07245810

Stryker Facial iD Universal Plate Configurator: A Retrospective Post Market Follow Up

A retrospective post market follow up to confirm safety and performance of Stryker's Facial iD Universal Plate Configurator (UPC) implants in the clinical setting. The study is performed to confirm the product's performance and safety by systematically collecting clinical data on its use.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Key information

Sex eligibility

All sexes

Study type

Observational

Primary location

New York Center for Orthognathic and Maxillofacial Surgery, New York, United States

Loading trial locations.

About this study

This is a retrospective non-interventional post-market follow up aiming at confirming safety and performance of Stryker's Facial iD UPC plating system when used in the clinical setting. This study will include patients who have previously undergone a surgical procedure involving the Study Device, with surgical outcomes evaluated retrospectively. Based on a non-inferiority study power calculation a minimum of 80 patients will be enrolled in the study. Additional patients may be enrolled up to 800 subjects depending on site enrolment rate and patient availability. Up to 3 investigational sites within the United States will participate in this study. The primary outcome parameter evaluating successful fixation or reconstruction of the midface without the need for unplanned revision surgery will be evaluated at all available follow-up timepoints of the included patients.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients who received a Stryker UPC plate for osteotomy, stabilization and rigid fixation of maxillofacial fractures or reconstruction as per routine clinical practice
  • Patients for whom data on the primary outcome variable is available.

Exclusion criteria

  • Patients with non-reducible and unstable fractures at the time of surgery
  • Patients with fractures of a severely atrophic mandible at the time of surgery
  • Patients with active local infections at the time of surgery
  • Patients with metal allergies and/or foreign body sensitivity at the time of surgery
  • Patients with limited blood supply or insufficient quality or quantity of bone at the time of surgery
  • Potentially non-compliant patients who are unwilling or incapable of following postoperative care instructions

Treatment and study plan

Orthognatic surgery, Reconstructive maxillofacial surgery, Mandible and maxillofacial trauma surgery

Device

Osteotomy, Mandible and Maxillofacial reconstruction, Orthognathic surgery

Primary outcomes

  1. Successful fixation or reconstruction of the midface without the need for unplanned revision surgery.

    Time frame: Data collected at a single time point per patient in the course of 18 months.

    Assessed by reviewing adverse events in patient medical charts at time point after surgery. Used to document whether an unplanned revision surgery was required or not for patients.

Secondary outcomes

  1. Infection rate

    Time frame: Data collected at time points from patient medical charts in the course of 18 months.

    Determined by adverse events reported from patient medical charts.

  2. Intraoperative complications

    Time frame: Data collected at a single time point per patient in the course of 18 months.

    Determined by adverse events reported from patient medical charts.

  3. Postoperative complications

    Time frame: Data collected at time points per patient in the course of 18 months.

    Determined by adverse events reported from patient medical charts.

  4. Any known adverse events

    Time frame: Data collected at time points per patient in the course of 18 months.

    Determined by adverse events reported from patient medical charts.

  5. Plate failure

    Time frame: Data collected at time points point per patient in the course of 18 months.

    Determined by adverse events reported from patient medical charts.

  6. Satisfactory occlusion achieved after additional orthodontic treatment

    Time frame: Data collected at a single time point per patient in the course of 18 months.

    Data reported in patient medical charts

  7. Time to return to solid food/normal diet

    Time frame: Data collected at a single time point per patient in the course of 18 months.

    Time for patient to return to solid food/normal diet post operation (dd)

  8. Hospitalization time; ICU and normal ward

    Time frame: Data collected at a single time point per patient in the course of 18 months.

    Time the patient was hospitalized post procedure (dd:hh)

  9. EuroQol-5 Domain Questionnaire (if available)

    Time frame: Data collected at time points per patient in the course of 18 months.

    A descriptive system and a visual analogue scale (VAS). The descriptive system comprises five dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression, each with three to five levels of severity. The VAS provides a subjective rating of overall health on a scale from 0 to 100 (higher is better)).

  10. Facial Appearance, Quality of Life, and Satisfaction Questionnaire (if available)

    Time frame: Data collected at time points per patient in the course of 18 months.

    40 independently functioning scales and checklists. Multiple independent scales, each with a 0-100 score, where higher scores indicate better outcomes. Scores are calculated by summing responses on a 4-point Likert scale (e.g., strongly disagree to strongly agree), which are then converted to the 0-100 range. Each scale measures a specific aspect of facial appearance, quality of life, or adverse effects and cannot be summed into a single total score.

  11. 12-Item Short Form Health Survey (SF-12)

    Time frame: Data collected at time points per patient in the course of 18 months.

    12 items grouped and scored to produce two separate summary scores: the Physical Component Summary (PCS-12) and the Mental Component Summary (MCS-12). The scale is transformed to a 0-100 range with higher scores indicating better health.

Other outcomes

  1. Primary indication for the surgery / diagnosis

    Time frame: Data collected at a single time point per patient in the course of 18 months.

    Diagnosis collected from patient medical charts.

  2. Max follow-up time

    Time frame: Data collected at a single time point per patient in the course of 18 months.

    Maximum post operative follow up time for patients within standard of care. Reported in patient medical charts during hospital follow up visits.

  3. Surgical approach

    Time frame: Data collected at a single time point per patient in the course of 18 months.

    Surgical approach taken for the procedure. Including: transoral; intraoral; maxillary vestibular approach; transbuccal; submandibular; preauricular; other

  4. Medical conditions

    Time frame: Data collected at time points point per patient in the course of 18 months.

    Underlying medical conditions and medication that may be related to the device or primary outcome.

  5. Localization of the defect

    Time frame: Data collected at a single time point per patient in the course of 18 months.

    Area to treated by the device: mandibular ramus; mandibular body; mandibular condyle; parasymphysis; paramedian; Le Fort I; Le Fort II; Le Fort III; others

  6. Post operative maxillo-mandibular fixation

    Time frame: Data collected at a single time point per patient in the course of 18 months.

    For patients that receive maxillo-mandibular fixation post operation the length of time after surgery the fixation procedure took place (days).

  7. Patient Radiation Exposure

    Time frame: Data collected at time points per patient in the course of 18 months.

    Exposure of patient to radiation therapy within 12 months around the surgery date recorded in patient medical charts (number and type of radiation procedures performed).

    Radiation therapy performed on the anatomical area treated with the device.

    Any postoperative radiation therapy recorded in patient medical charts.

  8. Sterilization method used

    Time frame: Data collected at a single time point per patient in the course of 18 months.

    Sterilization method used for the device. Qualitative responses from site.

  9. Fixation system used

    Time frame: Data collected at a single time point per patient in the course of 18 months.

    System used to fix the device during the procedure. Stryker Universal CMF screws; others

  10. Tightening of screws

    Time frame: Data collected at a single time point per patient in the course of 18 months.

    Tools used to fix the device during the procedure. Response options include :

    Manual and electric screw driver

  11. Orthognathic cases

    Time frame: Data collected at a single time point per patient in the course of 18 months.

    Usage of splints in orthognathic cases.

  12. Year smoking was stopped

    Time frame: Data collected at time points per patient in the course of 18 months.

    Year smoking was stopped (YYYY)

  13. Smoking frequency

    Time frame: Data collected at time points per patient in the course of 18 month

    The frequency of exposure to smoking during periods of smoking (average number of cigarettes per day).

  14. Smoking duration

    Time frame: Data collected at time points per patient in the course of 18 month

    Duration of smoking (pack years)

  15. Years of active smoking

    Time frame: Data collected at time points per patient in the course of 18 month

    Total number of years active smoker (YY)

  16. Patient weight

    Time frame: Data collected at a single time point per patient in the course of 18 months.

    Weight (kg, lb)

  17. Patient height

    Time frame: Data collected at a single time point per patient in the course of 18 months.

    Height (cm, feet, inches)

  18. Patient age

    Time frame: Data collected at a single time point per patient in the course of 18 months.

    Age (years)

  19. Gender

    Time frame: Data collected at a single time point per patient in the course of 18 months

    Responses: Male, Female, undifferentiated, unknown

Sponsors and collaborators

Lead sponsor

Stryker Craniomaxillofacial

Industry

Registry information

Official study title

Stryker Facial iD Universal Plate Configurator: A Retrospective Post Market Follow Up to Confirm Safety and Performance

Acronym: UPC

Important dates

Study start
2024
Primary completion
2026
Study completion
2026
First posted
Nov 24, 2025
Registry last updated
Apr 22, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.